Clinical Trials Directory

Trials / Terminated

TerminatedNCT01319747

Video-Assisted Thoracoscopic Pulmonary Vein Isolation Versus Percutaneous Catheter Ablation in Atrial Fibrillation Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
77 (actual)
Sponsor
Medisch Spectrum Twente · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Recent studies demonstrated that radiofrequency isolation of the pulmonary veins (PVI) and surgically video assisted thorascopic pulmonary vein isolation (VATS-PVI) are acceptable or even superior alternatives to antiarrhythmic drug therapy in patients with symptomatically paroxysmal atrial fibrillation (AF). However, data comparing effectiveness in both interventions are limited. The investigators want to compare the effectiveness of PVI and VATS-PVI. Secondary objectives are to compare the duration of hospitalization, quality of Life, cost and to compare the satisfaction of the patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREPVIFor catheter ablation, we used irrigated 4mm RF-ablation catheters, at a maximum power of 30-35Watt, an irrigation rate of 20 mL/min. PV isolation was performed by wide circumferential ablation, encircling all ipsilateral PVs.
PROCEDUREVATS-PVIA bilateral video-assisted thoracoscopic (VATS) pulmonary vein isolation and left atrial appendage (LAA) excision is performed under general anaesthesia and double-lumen endotracheal ventilation.

Timeline

Start date
2010-09-01
Primary completion
2013-11-01
Completion
2014-11-01
First posted
2011-03-22
Last updated
2024-11-22

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01319747. Inclusion in this directory is not an endorsement.

Video-Assisted Thoracoscopic Pulmonary Vein Isolation Versus Percutaneous Catheter Ablation in Atrial Fibrillation Trial (NCT01319747) · Clinical Trials Directory